News | Precision Medicine A

News

Aug 17

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO®

TOKYO and XIAMEN, August 17, 2021 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...

Jun 30

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic...

TOKYO and XIAMEN, June 30, 2021 (GLOBE NEWSWIRE) -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...

Nov 23, 2019

Poster at ESMO Asia 2019:: LC-SCRUM Presents Initial International Screening Results

PREMIA and AmoyDx Announce Strategic Partnership
to Establish Asia Cancer Clinical Genomic Network

Jun 24, 2019

PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network

Hong Kong, China -- June 24, 2019 – Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic...

May 31, 2019

LC-SCRUM Japan Expands Genomic Screening Project to Taiwan and Establishes LC-SCRUM Asia

The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project...